MetaCap

Who Owns CytomX Therapeutics Stock?

NASDAQ: CTMXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.03-0.02 (-0.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
102.88%
Institutional holders
254
  • Institutions 99.4%
  • Insiders 0.6%
  • Public and other 0.0%

Who owns CytomX Therapeutics stock?

Institutional investors own about 102.9% of CytomX Therapeutics's shares, spread across 254 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.57% of CTMX.

The largest institutional holders are FMR, LLC (15.75%), Kynam Capital Management, LP (9.70%) and Blackrock Inc. (8.47%). Together, the top 10 institutions control 61.3% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their CTMX positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CTMX

CytomX Therapeutics top institutional holders
InstitutionShares% HeldChange
FMR, LLC34.34M15.75%+5.0%
Kynam Capital Management, LP21.14M9.70%-2.6%
Blackrock Inc.18.47M8.47%+5.2%
Bank of America Corporation11.57M5.31%-23.3%
Perceptive Advisors Llc9.27M4.25%-11.2%
State Street Corporation9.03M4.14%-23.2%
Vanguard Capital Management LLC8.73M4.01%+2.4%
Point72 Asset Management, L.P.8.60M3.95%+10.2%
Citadel Advisors Llc7.01M3.22%+125.4%
Two Sigma Investments, LP5.38M2.47%+30.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CTMX

CytomX Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund6.23M2.86%
Fidelity Select Portfolios-Select Health Care Portfolio6.00M2.75%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF5.08M2.33%
iShares Trust-iShares Russell 2000 ETF4.88M2.24%
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 4.75M2.18%
Fidelity Securities Fund-Fidelity Small Cap Growth Fund3.97M1.82%
Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund3.00M1.38%
Fidelity Select Portfolios-Select Biotechnology Portfolio2.79M1.28%
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund2.49M1.14%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund2.10M0.96%

Frequently asked questions

Who is the largest shareholder of CytomX Therapeutics?

FMR, LLC is the largest institutional shareholder of CTMX, owning 15.75% of shares outstanding (34.34M shares) as of its latest 13F filing.

What percentage of CytomX Therapeutics is owned by institutions?

Institutions own about 102.9% of CTMX shares and 103.5% of the public float.

How much of CytomX Therapeutics do insiders own?

Insiders, such as officers and directors, own about 0.57% of CTMX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related